单位(元)易方达医药生物股票C(010388)资产负债表 |
| 报告期 |
2025/12/31 |
2025/6/30 |
2024/12/31 |
2024/6/30 |
| 资产 |
| 银行存款 |
271,154,752 |
331,510,305 |
311,434,310 |
229,586,178 |
| 结算备付金 |
1,458,841 |
13,361,760 |
8,165,088 |
2,255,991 |
| 存出保证金 |
451,640 |
502,213 |
330,711 |
248,011 |
| 交易性金融资产 |
2,754,467,601 |
2,817,172,101 |
2,911,745,668 |
2,874,084,619 |
| 其中：股票投资 |
2,754,467,601 |
2,817,172,101 |
2,911,745,668 |
2,870,873,883 |
| 基金投资 |
- |
- |
- |
- |
| 债券投资 |
- |
- |
- |
3,210,735 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
12,304,631 |
- |
70,136,248 |
9,213,684 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
4,147,559 |
- |
1,792,376 |
| 应收申购款 |
11,515,037 |
8,879,789 |
3,518,647 |
22,328,145 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
3,051,352,502 |
3,175,573,727 |
3,305,330,672 |
3,139,509,003 |
| 负债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
38,203,706 |
12,433,873 |
5,398,901 |
| 应付赎回款 |
74,742,162 |
68,116,457 |
160,772,902 |
6,318,103 |
| 应付管理人报酬 |
3,360,498 |
3,382,203 |
3,503,833 |
3,186,996 |
| 应付托管费 |
560,083 |
563,700 |
583,972 |
531,166 |
| 应付销售服务费 |
436,739 |
344,725 |
447,465 |
390,276 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
7 |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
1,040,183 |
2,081,006 |
1,397,672 |
896,831 |
| 负债合计 |
80,139,663 |
112,691,796 |
179,139,717 |
16,722,281 |
| 所有者权益 |
| 实收基金 |
3,743,048,622 |
3,894,662,107 |
5,302,435,396 |
5,396,093,560 |
| 未分配利润 |
-771,835,783 |
-831,780,176 |
-2,176,244,441 |
-2,273,306,838 |
| 所有者权益合计 |
2,971,212,838 |
3,062,881,931 |
3,126,190,955 |
3,122,786,722 |
| 负债和所有者权益总计 |
3,051,352,502 |
3,175,573,727 |
3,305,330,672 |
3,139,509,003 |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。
